首页 正文

The changing face of spondyloarthropathies under TNF α blockade

{{output}}
Objectives: Tumor necrosis factor alpha (TNF-α ) therapy has been implicated in the development of autoimmune diseases. Our aim was to describe three patients with spondyloarthropathies who responded to infliximab, a chimeric mo... ...